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Abstract&
Improvements+ in+survival+ for+Ewing+sarcoma+pediatric+and+adolescent+patients+have+been+modest+over+ the+ past+ 20+ years.+ Combinations+ of+ anticancer+ agents+ endure+ as+ an+ option+ to+ overcome+resistance+ to+ single+ treatments+ caused+ by+ compensatory+ pathways.+ Moreover,+ combinations+ are+thought+to+lessen+any+associated+adverse+side+effects+through+reduced+dosing,+which+is+particularly+important+ in+ childhood+ tumors.+ Using+ a+ parallel+ phenotypic+ combinatorial+ screening+ approach+ of+cells+derived+from+three+pediatric+tumor+types,+we+identified+Ewing+sarcoma+5specific+interactions+of+a+ diverse+ set+ of+ targeted+ agents+ including+ approved+ drugs.+ We+ were+ able+ to+ retrieve+ highly+synergistic+ drug+ combinations+ specific+ for+ Ewing+ sarcoma+ and+ identified+ signaling+ processes+important+for+Ewing+sarcoma+cell+proliferation+determined+by+EWS5FLI1.+We+generated+a+molecular+target+ profile+ of+ PKC412,+ a+ multikinase+ inhibitor+ with+ strong+ synergistic+ propensity+ in+ Ewing+sarcoma,+ revealing+ its+ targets+ in+ critical+ Ewing+ sarcoma+ signaling+ routes.+ Using+ a+ multilevel+experimental+ approach+ including+ quantitative+ phosphoproteomics,+ we+ analyzed+ the+ molecular+rationale+behind+ the+disease5specific+ synergistic+effect+of+ simultaneous+application+of+PKC412+and+IGF1R+inhibitors.+The+mechanism+of+the+drug+synergy+between+these+inhibitors+is+different+from+the+sum+ of+ the+ mechanisms+ of+ the+ single+ agents.+ The+ combination+ effectively+ inhibited+ pathway+crosstalk+and+averted+feedback+loop+repression,+in+EWS5FLI1+dependent+manner.+++ +
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Introduction&
Pediatric+tumors+are+highly+diverse+regarding+their+cells+of+origin,+clinical+ features+and+onset+time.+Childhood+ cancer+ is+ mainly+ a+ consequence+ of+ altered+ regulation+ of+ normal+ tissue+ development.+Furthermore,+ in+most+childhood+tumors+only+a+ few+mutations+have+been+ found+ in+genes+ that+code+for+druggable+targets,+thus+rendering+it+more+difficult+to+design+therapeutic+strategies.+Among+solid+pediatric+tumors+the+overall+survival+rate+for+recurrent+or+metastatic+disease+is+ less+than+30%+and+many+childhood+cancer+survivors+experience+ long5term+effects+as+a+consequence+of+ treatment+that+severely+ reduce+ their+ quality+ of+ life+ (1).+ Other+ than+ neuroblastoma,+ the+ 55year+ survival+ rates+ for+pediatric+and+adolescent+solid+tumors+have+not+changed+over+the+past+two+decades,+particularly+true+in+ case+ of+ pediatric+ and+ adolescent+ sarcomas+ (2).+ Ewing+ sarcoma+ is+ the+ second+ most+ common+pediatric+ bone+ tumor+ but+ can+ develop+ in+ soft+ tissue+ as+ well+ (extra5skeletal+ Ewing+ sarcoma).+ The+disease+ onset+ usually+ in+ adolescent+ years+ with+ peak+ occurrence+ between+ ages+ 10+ and+ 20.+ A+ vast+number+of+childhood+tumors+have+quiet+genomes,+and+Ewing+sarcoma+has+one+of+the+quietest+of+all+(3).+ The+ FET$ETS+ fusion+ is+ the+ defining+molecular+ feature,+most+ commonly+ involving+EWSR1+ and+
FLI1+(4,5).+STAG2,+CDKN2A+and+TP53+are+the+only+other+genes+found+to+be+affected+in+up+to+20%+of+cases;+the+prognostic+significance+of+these+mutations+remains+controversial+(3,6–8).+The+EWS5FLI1+fusion+oncoprotein+ is+a+ result+of+a+chromosomal+ translocation+ t(11:22)+between+ the+central+exons+5´portion+of+the+EWSR15(EWS)+gene+(Ewing+sarcoma+breakpoint+region+1,+at+chromosome+22)+to+the+central+exons+and+the+DNA+binding+domain+containing+portion+of+an+ETS5(E5twenty5six)+family+gene,+most+ commonly+ FLI1+ (Friend+ leukemia+ integration+ 1,+ chromosome+ 11).+ EWS5FLI1+ is+ an+ aberrant+transcription+factor+which+is+considered+the+main+pathogenic+driver+of+the+disease+(9)+since+~85%+Ewing+ sarcoma+ cases+ are+ characterized+ by+ its+ presence.+ EWS5FLI1+ mediates+ malignant+transformation+and+drives+the+target+gene+expression+(10,11).+Transcription+factors+are+per+se+very+challenging+ drug+ targets+ since+ they+ lack+ a+ druggable+ pocket;+ their+ functional+ domains+ are+ less+structurally+ susceptible+ compared+ to+ the+ enzymatic+ ones.+ Moreover,+ it+ is+ difficult+ to+ directly+modulate+ protein/DNA+binding.+ Thus,+ current+ studies+ have+mainly+ focused+ on+ targeting+ signaling+pathways+ that+ regulate+ the+ activity+ of+ EWS5FLI1.+ Initial+ promising+ results+ coincided+ with+ the+availability+of+compounds+that+target+molecules+associated+with+Ewing+sarcoma+progression,+such+as+CDKs,+ pro5apoptotic+ proteins+ and+ certain+ tyrosine+ kinases,+ e.g.+ realization+ of+ the+ importance+ of+ROR1+ in+ metastatic+ disease+ (12).+ The+ contribution+ of+ IGF1R/Insulin+ receptor+ (IGF1R/INSR)+signaling+ pathway+ to+ Ewing+ sarcoma+ neoplastic+ transformation+ is+ widely+ accepted+ (13,14).+ IGF1+(Insulin5like+ growth+ factor+ 1)+ is+ a+ growth+ factor+ deposited+ in+ the+ bone+ matrix,+ and+ it+ is+ no+coincidence+ that+ the+ peak+ of+ occurrence+ of+ Ewing+ sarcoma+ coincides+ with+ accelerated+ growth+ in+
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puberty,+ where+ IGF1+ plays+ a+ major+ role.+ IGF1,+ together+ with+ few+ other+ members+ of+ the+ same+signaling+axis,+is+induced+by+the+EWS5FLI1+fusion+protein+(15).+IGF1+stimulates+IGF1R+receptors+and+triggers+ growth+ and+ pro5survival+ pathways+ (PI3K+ and+ RAS),+ thus+ creating+ a+ perfect+ niche+ for+malignant+ transformation+ of+ cells.+ Whereas+ the+ response+ to+ IGF1R+ inhibitors+ was+ dramatic+ in+ a+certain+number+of+patients,+the+overall+rate+was+discouraging.+The+reported+resistance+to+anti5IGF1R+therapies+is+often+caused+by+the+activation+of+bypass+pathways+(16).+The+PI3K/AKT/mTOR+pathway+plays+ an+ important+ role+ in+ Ewing+ sarcoma+ progression,+ as+ in+ many+ other+ malignancies+ (17).+Furthermore,+ the+ MAPK/ERK+ pathway+ is+ involved+ in+ regulation+ of+ cellular+ responses+ to+ diverse+range+ of+ extracellular+ stimuli+ including+ mitogens,+ growth+ factors,+ and+ cytokines,+ making+ it+ an+important+target+in+the+diagnosis+and+treatment+of+various+cancers,+ including+Ewing+sarcoma+(18).+Changes+ in+ calcium5dependent+ signaling+ mechanisms+ are+ frequently+ altered+ and+ remodeled+ in+cancer+ cells,+ including+Ca2++ sensors+ and+effectors,+ such+ as+ calmodulin+ (CAM)+and+ the+downstream+targets,+including+CAM+kinase+(CAMK),+calcineurin+and+protein+kinase+C+(PKC).+Although+a+number+of+ potential+molecular+ targets+ have+ been+ proposed+ for+ Ewing+ sarcoma,+ such+ are+ IGF1R+ and+ other+receptor+ tyrosine+ kinases+ inhibitors,+mTOR+and+ certain+EWS5FLI1+ related+ targets,+ the+ therapeutic+efficacy+of+their+inhibition+is+still+modest,+due+to+the+lack+of+biomarkers+and+drug+resistance,+which+lead+to+rather+disappointing+clinical+data+(19).+The+occurrence+of+drug+resistance+could+be+prevented+or+ partly+ delayed+ by+ applying+ the+ concurrent+ combination+ treatment.+ A+ synergistic+ drug+combination+ is+ more+ potent+ than+ equally+ effective+ doses+ of+ its+ components+ (20),+ thus+ providing+additional+benefit+to+patient+over+a+simple+increase+in+single+dosages.++In+ this+ study+ we+ used+ a+ parallel+ screening+ approach+ to+ contrast+ combinatorial+ screens+ in+ three+pediatric+ tumor+ entities+ and+ to+ identify+ combinations+ of+ targeted+ agents+ that+ act+ highly+synergistically+ in+ a+ signaling+ context+ specifically+ altered+ by+ EWS5FLI1+ expression.+ A+ drug+ library+focused+ on+ clinically+ relevant+ agents+ allowed+ us+ to+ discover+ combinations+with+ a+ potential+ to+ be+translated+ into+ clinical+ treatment.+ Preclinical+ studies+ are+ required+ to+ determine+ the+pharmacodynamic+ interactions+ and+ appropriately+ adjust+ in5 vivo+ dosing+ regimens.+ However,+ a+broader+ concentration+ range+ where+ synergistic+ effect+ is+ preserved+ offers+ a+ higher+ probability+ of+achieving+ the+ desired+ plasma+ concentration.+ Thus,+ we+ focused+ on+ combinations+ that+ showed+ a+robust+synergy.+In+the+context+of+Ewing+sarcoma,+defined+by+the+presence+and+activity+of+the+EWS5FLI1+ fusion+ protein,+ we+ analyzed+ the+ molecular+ rationale+ behind+ the+ Ewing+ sarcoma+ 5specific+synergistic+effect+of+simultaneous+application+of+PKC412+and+IGF1R+inhibitors+using+a+multi5pronged+experimental+approach.+PKC412+(midostaurin)+ is+an+oral,+multi5targeted+kinase+ inhibitor,+ recently+approved+by+the+FDA+for+treatment+of+patients+with+FLT35mutated+acute+myeloid+ leukemia+(AML)+
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and+ in+ phase+ II+ trial+ for+ mast+ cell+ leukemia+ (MCL)+ and+ aggressive+ systemic+ mastocytosis+ (ASM).+Moreover,+PKC412+has+been+shown+to+induce+apoptosis+of+Ewing+sarcoma+cells+in+vitro+and+in+vivo+(21).+We+implemented+chemical+proteomics+to+profile+the+PKC412+target+spectrum+in+the+context+of+Ewing+sarcoma+and+investigated+the+molecular+effects+elicited+by+the+simultaneous+application+with+the+ IGF1R/INSR+ inhibitors.+ OSI5906+ and+ BMS5754807+ are+ oral,+ reversible+ ATP5competitive+antagonists+ of+ insulin5like+ growth+ factor+ 1+ receptor+ (IGF1R).+ Unlike+ anti5IGF1R+ monoclonal+antibodies,+ they+ also+ block+ the+ insulin+ receptor+ and+ the+ hybrid+ dimers+ (IGF1R/INSR)+ which+ is+advantageous+in+cancer+treatment+(22).+Moreover,+both+OSI5906+and+BMS5754807+are+judged+to+be+rather+specific,+with+BMS5754807+shown+to+inhibit+only+a+few+other+kinases+although+with+markedly+lower+ potency+ than+ IGF1R+ and+ INSR+ (23).+ We+ identified+ the+ signaling+ routes+ in+ Ewing+ sarcoma+whose+ synchronous+ inhibition+allowed+achieving+a+potent+elimination+of+ tumor+cells+ and+effective+surpassing+of+the+induction+of+compensatory+signaling+pathways.+
Materials&and&Methods+
Viability5assays5The+ individual+drug+effects+were+determined+ in+proliferation+assays+using+Cell+Titer+Glo+(Promega+Inc.,+Madison+WI,+USA).+4+×10³+ cells+were+ seeded+ in+965well+plates+ in+ triplicates+ and+ treated+with+drugs+24+h+after.+Serial+dilutions+in+a+range+between+20+µM+and+0.05+µM+were+applied+for+72+hours.+In+ case+of+knockdown+of+EWS5FLI1,+ the+ induction+with+doxycycline+was+started+24h+prior+ to+drug+treatment+and+the+cells+were+kept+in+doxycycline+until+the+readout.+IC50+values+were+determined+by+fitting+ a+ dose+ response+ curve+ to+ the+ data+ points+ using+ non5linear+ regression+ analysis+ utilizing+ the+GraphPad+Prism+software.5
Compounds5PKC412+was+purchased+from+LC+Laboratories+(Woburn,+MA,+USA).+OSI5906+and+BMS5754807+were+purchased+from+Active+Biochem+(Kowloon,+Hong+Kong)+and+Selleck+Chemicals+(Munich,+Germany).+List+of+ all+ compounds+ included+ in+ the+ libraries+with+ their+ respective+manufacturers+ is+provided+ in+Supplementary+Table+S1.+All+compounds+were+dissolved+in+dimethyl+sulfoxide+(DMSO)+as+10+mM+or+5+mM+stock+solutions.+
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Determination5of5synergy5and5analysis5of5the5screen5The+ combination+ index+ (CI),+ see+ (24),+ was+ used+ for+ quantification+ of+ synergistic,+ antagonistic+ or+additive+ effects+ of+ each+ drug+ pair.+ In+ order+ to+ capture+ synergistic+ effect+ if+ present,+ we+ obtained+duplicate+ matrices+ for+ each+ drug+ pair,+ positioned+ in+ different+ screening+ plates.+ Cell+ viability+ was+measured+ across+ a+ range+ of+ dose+ levels+ for+ each+ drug+ pair+without+maintaining+ the+ ratio+ of+ dose+levels+constant.+In+its+conventional+terminology,+a+non5constant+ratio+experimental+design+has+been+deployed.+ Such+ an+ experimental+ setup+ has+ been+ selected+ for+ the+ purposes+ of+ attaining+ a+ broad+screening+across+drug+combinations+and+dose+levels.+The+well5known+implication+of+carrying+out+the+experiment+at+non5constant+dose+ratio+has+been+the+lack+of+ability+to+simulate+CI+across+varying+dose+levels+to+estimate+a+smooth+dose5response+curve.+However,+ it+has+been+possible+to+calculate+CI+ for+each+combination+data+point+under+ the+non5constant+ratio+design.+The+evaluated+CI+has+ then+been+mainly+employed+for+classifying+drug+pairs+as+synergistic+or+antagonistic+with+respect+to+CI+cut5offs,+thus+allowing+to+detect+drug+combinations+with+non5additive+signals.+Estimating+CI+for+a+given+drug+pair+at+an+observed+point+entails+a+two5step+process.+Initially,+the+kinetic+order+m+and+median+effect+dose+!!+ appearing+ in+median5effect+equation+(1)+are+estimated+ for+each+single+drug.+The+median5effect+equation+expresses+as+
!!!! = !!! ! ,+ (1)+where+ the+ observables+ are+ the+ fraction+ of+ unaffected+ (viable)+ cells+ !!+ and+ drug+ dose+ D,+ while+!! = 1 − !!+is+the+fraction+of+affected+(inhibited)+cells.+To+apply+equation+(1)+to+a+single+drug,+the+!! ,+!!,+and+D+values+ for+ that+drug+are+taken+ into+account+across+all+drug+pairs+at+ the+ instances+of+zero+dosage+ for+ the+ other+ drug+ in+ each+ pair.+ Equation+ (1)+ is+ then+ log5transformed,+ and+ simple+ linear+regression+ is+used+for+estimating+m+and+!! .+The+second+step+ involves+computing+the+combination+index+
!" = !!!! ! !!!! !!!! + !!!! ! !!!! !!!!,++ (2)+where+!! ,+ !! ! +are+the+dose+and+estimated+median+dose+for+drug+i,+! ∈ {1, 2},+in+the+pair.+
Apoptosis5measurements55Adherent+and+floating+cells+were+analyzed+24+hours+after+compound+treatment+with+the+AnnexinV+Apoptosis+ Detection+ Kit+ APC+ (eBioscience,+ San+ Diego,+ USA).+ AnnexinV+ and+ DAPI+ (Sigma5Aldrich)+staining+were+performed+according+to+manufacturer´s+instructions+and+FACS+Fortessa+(BD)+and+the+
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Diva+software+(BD,+Version)+were+used+for+quantification+purposes.+As+a+positive+control,+apoptosis+was+induced+via+camptothecin+(1+µM+for+24h).+
Colony5formation5assay551×10⁴+cells+per+well+were+seeded+ in+six5well+plates+ in+ triplicates.+After+24+h+treatment+with+DMSO+(equal+to+the+highest+amount+of+compound+dilution,+maximum+0.2%)+or+compounds+at+combination+concentrations+ were+ added+ and+ cells+ incubated+ at+ 37+ °C,+ 5%+ CO2+ for+ 7–10+ days.+ Medium+ was+aspirated,+ cells+ were+ washed+ with+ PBS+ (Gibco),+ stained+ with+ crystal+ violet+ solution+ (0.5%+ in+ 6%+glutaraldehyde)+ and+ left+ to+ dry+ overnight.+ For+ quantification+ of+ results,+ ultraviolet+ absorbance+ of+crystal+ violet+ was+ determined+ at+ 570+ nm+ following+ solubilization+ by+ 70%+ ethanol.+ Data+ were+analyzed+using+the+GraphPad+Prism+software+(t5test,+p=0.05).+
Real$time5PCR5analysis55RNeasy+Mini+Kit+ (Qiagen)+was+used+ for+ the+ isolation+of+ total+RNA.+Total+RNA+was+quantified+using+NanoDrop+spectrophotometer+(Thermo)+and+cDNA+was+synthesized+from+500+ng+of+RNA+via+reverse+transcription+ using+ oligo(dT)+ primers+ and+ RevertAid+ Reverse+ Transcriptase+ (Fermentas).+Quantitative+PCR+was+carried+out+on+a+RotorGene+RG5600+(Qiagen)+PCR+machine+using+the+SensiMix+SYBR+kit+(Bioline).+Results+were+quantified+using+the+25ΔΔC(t)+method,+using+GAPDH+expression+levels+for+normalization.+
Cell5culture55The+ SH5SY5Y,+ IMR5575,+ and+ UW228+ cell+ lines+ were+ received+ as+ generous+ gifts+ from+ Drs.+ Frank+Westermann+ and+ Alexandre+ Arcaro+ (obtained+ in+ 2011).+ A673+ and+ A673+ EWS5FLI1+ conditional+knockdown+ cell+ lines+ were+ a+ kind+ gift+ from+ Dr.+ Javier+ Alonso+ (obtained+ in+ 1992+ and+ 2007,+respectively).+TC252,+TC32,+RDES,+STA5ET57.1,+STA5ET57.2,+STA5ET52.1,+STA5ET52.2+and+TC71+Ewing+sarcoma+cell+lines+were+acquired+by+Dr.+Heinrich+Kovar+(obtained+in+years+1992,+2005,+1992,+1992.,+1992,+ 1991,+ 1991+and+2006,+ respectively).+No+ authentication+was+done+by+ the+ authors.+A673+and+UW228+cells+were+cultured+ in+DMEM+(Sigma)+media+containing+10%+fetal+bovine+serum+and+10+U+mL51+ penicillin/streptomycin+ (Gibco).+ SH5SY5Y,+ TC252+ and+ IMR5575+ cells+ were+ cultured+ in+ RPMI+1640+ (Sigma)+ media+ containing+ 10%+ fetal+ bovine+ serum+ and+ 10+ U+ mL51+ penicillin/streptomycin+(Gibco).+ TC32,+ RDES,+ STA5ET57.1,+ STA5ET57.2,+ STA5ET52.1,+ STA5ET52.2+ and+ TC71+ were+ grown+ on+fibronectin+ (Roche)+ coated+ plates,+ and+ kept+ in+ RPMI+ 1640+ (Sigma)+ media+ containing+ 10%+ fetal+bovine+serum+and+10+U+mL51+penicillin/streptomycin+(Gibco).++
8"
"
Cell5stimulation5and5immunoblotting5Cells+were+cultured+in+complete+medium+and+serum+starved+over+night,+when+indicated.+Upon+the+2h+drug+ treatment,+ cells+ were+ stimulated+ for+ 20+ minutes+ with+ 15%+ serum+ media.+ In+ case+ of+ a+knockdown+ of+ EWS5FLI,+ cells+ were+ treated+ with+ doxycycline+ (1+ µg/mL)+ 72+ hours+ before+ serum+stimulation,+unless+otherwise+stated.+The+following+antibodies+were+used:+rabbit+anti5actin+(AAN01)+(Cytoskeleton,+AAN01),+mouse+anti5tubulin+ (DM1A)+ (Abcam,+ ab7291),+mouse+GAPDH+ (Santa+Cruz,+sc5365062),+ rabbit+ phospho5Akt+ (Ser473)+ (Cell+ Signaling,+ 4060S),+ rabbit+ phospho5Akt+ (Thr308)+(Cell+Signaling,+2965),+rabbit+Akt+(pan)+(11E7)+(Cell+Signaling,+4685),+rabbit+phospho5p70+S6+kinase+(Thr389)+ (Cell+ Signaling,+ 9234),+ rabbit+ p70+ S6+ kinase+ α+ (C518)+ (Santa+ Cruz,+ sc5230),+ rabbit+ FLI1+(Novus,+NB6005537),+rabbit+pIGF1R+β(Tyr1135/1136)/IR+β+(Tyr+1150/1151)+(Cell+Signaling,+3024),+rabbit+ IGF5I+ Receptor+ β+ Antibody+ (Cell+ Signaling,+ 3027),+ rabbit+ phospho5p44/42+ MAPK+ (Erk1/2)+(Thr202/Tyr204)+(Cell+Signaling,+4370),+mouse+Erk51/2+(Sigma,+M+5670).+
Determination5of5intracellular5drug5levels5via5Multiple5reaction$monitoring5assay52+ ×+ 105+ cells+were+ treated+with+ drugs+ at+ 37+ °C,+ as+ stated.+ Subsequently,+ cells+ were+washed+ three+times+ with+ ice5cold+ PBS+ and+ directly+ lysed+ in+ 300+ μl+ 80%+ ice5cold+ methanol.+ Lysates+ were+ then+cleared+ by+ centrifugation+ for+ 20+ min+ at+ 4+ °C+ at+ 16,000+ g,+ and+ supernatants+ were+ used+ for+ the+following+ quantifications+ by+ MS.+ Multiple+ reaction5monitoring+ settings+ were+ automatically+generated+ for+ every+ compound+ using+ the+ IntelliStart+ software+ (Waters),+ and+ quantification+ was+conducted+on+the+basis+of+the+intensity+of+three+daughter+ions.+5
Compound5immobilization5and5affinity5purification55Drug5affinity+matrices+were+prepared+as+described+previously+(25).+In+brief,+25+nmol+of+compound+was+immobilized+on+50+µL+NHS5activated+Sepharose+4+Fast+Flow+beads+(GE+Healthcare+Bio5Sciences+AB,+ Uppsala,+ Sweden).+ Affinity+ chromatography+ and+ elution+ were+ performed+ in+ duplicate+ as+reported+previously+(26)+using+10+mg+total+cell+lysate+as+a+protein+input+per+replicate.+
Solution5tryptic5digestion5and5peptide5purification55After+ elution,+ enriched+ proteins+ were+ reduced+ with+ dithiothreitol,+ cysteine+ residues+ alkylated+ by+incubation+with+iodoacetamide+and+the+samples+digested+with+modified+porcine+trypsin+(Promega,+Madison,+ WI).+ Five+ percent+ (and+ multiples+ thereof)+ of+ the+ digested+ samples+ were+ purified+ and+concentrated+ by+ C18+ reversed5phase+ material+ for+ subsequent+ duplicate+ analysis+ by+ gel5free+ one5dimensional+ liquid+ chromatography+ mass+ spectrometry+ (1D5LCMS).+ Details+ of+ the+ LCMS+methodology+are+as+previously+described+(27).++
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Protein5identification5in5chemical5proteomic5experiment55Peak+ extraction+ and+ conversion+ of+ raw+ MS+ files+ into+ the+ mgf+ format+ for+ subsequent+ protein+identification+was+performed+with+msconvert+(ProteoWizard+Library+v2.1.2708).+An+initial+database+search+ was+ performed+ with+ broader+ mass+ tolerance+ to+ re5calibrate+ the+ mass+ lists+ for+ protein+identification.+Mascot+ (version+2.3.02,+MatrixScience,+ London,+UK)+was+used+ for+ the+ initial+protein+database+search.+Error+tolerances+on+the+precursor+and+fragment+ions+were+±10+ppm+and+±0.6+Da,+respectively,+and+the+database+search+was+limited+to+fully5tryptic+peptides+with+maximum+1+missed+cleavage+ site.+ Carbamidomethyl+ cysteine+ and+methionine+oxidation+were+ set+ as+ fixed+ and+variable+modifications,+ respectively.+ Searches+ were+ performed+ against+ the+ human+ UniProtKB/SwissProt+database+v2014.07_20141023+(40,984+sequences+including+isoforms+obtained+from+varsplic.pl+(28)+and+ appended+ known+ contaminants).+ The+ initial+ peptide+ identifications+ were+ used+ to+ deduce+independent+ linear+ transformations+ for+ precursor+ and+ fragment+masses+ that+would+minimize+ the+mean+ square+ deviation+ of+ measured+ masses+ from+ theoretical.+ Re5calibrated+ mass+ list+ files+ were+searched+ against+ the+ same+ human+ protein+ database+ by+ the+ Mascot+ and+ Phenyx+ (version+ 2.5.14,+GeneBio+SA,+Geneva,+Switzerland)+search+engines+with+narrower+mass+tolerances+(±4+ppm+and+±0.3+Da).+ To+ validate+ the+ proteins,+ Mascot+ and+ Phenyx+ output+ files+ were+ processed+ by+ internally5developed+ parsers.+ Proteins+ with+ ≥2+ unique+ peptides+ above+ a+ score+ T1,+ or+ with+ a+ single+ peptide+above+ a+ score+ T2+ were+ selected+ as+ unambiguous+ identifications.+ Additional+ peptides+ for+ these+validated+ proteins+ with+ score+ >+ T3+ were+ also+ accepted.+ For+ Mascot+ searches,+ the+ following+thresholds+were+used:+T1=14,+T2=40+and+T3=10;+Phenyx+thresholds+were+set+ to+4.2,+4.75+and+3.5,+respectively+(P5value+<+1053).+The+validated+proteins+retrieved+by+the+two+algorithms+were+merged,+any+ spectral+ conflicts+discarded+and+grouped+according+ to+ shared+peptides.+A+ false+discovery+ rate+(FDR)+of+<+1%+for+protein+identifications+and+<0.1%+for+peptides+(including+the+ones+exported+with+lower+ scores)+ was+ determined+ by+ applying+ the+ same+ procedure+ against+ a+ database+ of+ reversed+protein+sequences.++
Bioinformatic5analysis5of5drug5pulldown5data5The+specificity+of+the+compound+–+protein+interactions+generated+by+the+pull+down+experiment+was+assessed+ using+ the+ software+ SAINT+ (29)(version+ 2.4.0).+ Using+ the+ protein+ spectral+ counts+ as+measurement+of+abundance,+SAINT+algorithm+compares+the+protein+spectral+counts+of+the+pull+down+experiment+ and+ the+negative+ control+ as+ a+measurement+ of+ differential+ abundance+ to+ calculate+ the+probability+of+a+bait5pray+interaction+to+be+true.+The+fold+change+of+the+spectral+counts+is+based+on+computing+the+ratio+of+the+median+spectral+counts+with+or+without+competition+with+free+compound.+To+ eliminate+ background+ contaminants+ the+ CRAPome+ database+ was+ used+ (30).+ CRAPome+ is+ a+
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repository+ of+ negative+ controls+ generated+ by+ previous+ proteomics+ experiments+ and+ calculates+ a+score+for+the+interaction+data+as+15+number+of+experiments+the+protein+is+found+in+the+database/total+number+of+experiments+in+the+database.+The+protein+interaction+networks+were+created+by+using+the+STRING+database+(version+10).+Experimentally+obtained+interactions+were+filtered+and+a+confidence+score+ threshold+ of+ 0.7+ (high+ confidence)+ was+ required.+ Protein+ compound+ associations+ were+extracted+from+the+database+STITCH+(version+4.0).+ Interactions+derived+from+experiments+but+also+interactions+ extracted+ from+ other+ databases+ were+ used+ and+ a+ minimum+ threshold+ of+ STITCH+confidence+score+of+0.7+(high+confidence)+was+required.+Enrichment+analysis+was+performed+using+the+ Gene+ Set+ Enrichment+ Analysis+ (GSEA)+ tool+ and+ pathway+ annotation+ was+ based+ on+ the+ KEGG+ontology+database+with+an+FDR+cutoff+of+0.05.+For+network+visualization+and+further+data+integration+we+used+the+Cytoscape+platform+(version+3.2.1).+
SILAC5labeling5and5cell5treatments5For+quantitative+MS5based+phosphoproteomics,+the+A673+cell+line+was+labeled+in+SILAC+DMEM+(PAA+Laboratories+GmbH)+supplemented+with+10%+dialyzed+ fetal+bovine+serum+(Sigma),+ respectively,+2+mM+ l5glutamine+ (Gibco),+ 1+mM+sodium+pyruvate+ (Gibco),+ penicillin+ (100+U/ml),+ and+ streptomycin+(100+ μg/ml)+ for+ at+ least+ 7+ passages+ to+ ensure+ complete+ incorporation+ of+ amino+ acids.+ Three+ cell+populations+were+obtained:+one+labeled+with+natural+variants+of+the+amino+acids+(light+ label;+Lys0,+Arg0)+ (Sigma),+ the+ second+ labeled+with+medium+ variants+ of+ amino+ acids+ {L5[2H4]Lys+ (+4)+ and+ L5[13C6]Arg+ (+6)}+ (Lys4,+ Arg6),+ and+ the+ third+ labeled+ with+ heavy+ variants+ of+ the+ amino+ acids+ {L5[13C6,15N2]Lys+ (+8)+ and+L5[13C6,15N4]Arg+ (+10)}+ (Lys8,+Arg10).+Medium+and+heavy+ variants+ of+amino+ acids+were+ purchased+ from+Cambridge+ Isotope+ Laboratories.+ Cells+ from+ light,+medium+ and+heavy+ SILAC+ conditions+ were+ starved+ by+ replacing+ complete+ SILAC+medium+with+ SILAC+minimal+medium+ without+ serum+ over+ night.+ Cells+ were+ pretreated+ for+ 2+ hours+ with+ 75+ nM+ (0.25+ IC50)+PKC412+and+18+nM+(0.25+IC50)+BMS5754807;+alone+or+in+combination+and+0.1%+DMSO+was+used+as+control.+Then,+cells+were+stimulated+with+serum+for+20+minutes+and+lysed+separately+at+4°C+in+ ice5cold+modified+RIPA+buffer+ [50+mM+tris5HCl+ (pH+7.5),+150+mM+NaCl,+1+mM+EDTA,+1%+NP540,+0.1%+sodium+deoxycholate+with+the+addition+of+5+mM+β5glycerophosphate,+5+mM+sodium+fluoride,+1+mM+sodium+orthovanadate,+ and+one+Complete+Protease+ Inhibitor+Cocktail+ tablet+ (Roche)+per+50+ml+ of+solution].+
Sample5preparation5for5phosphoproteomic5MS5analysis5Proteins+ were+ precipitated+ overnight+ at+ −20°C+ using+ ice5cold+ acetone.+ The+ acetone5precipitated+proteins+were+solubilized+ in+denaturation+buffer+[6+M+Guanidine5HCl,+100+mM+tris+(pH+8.5),+5+mM+
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Tris+(25carboxyethyl)+phosphine+and+10+mM+chloroacetamide],+heated+at+99°C+and+sonicated.+12+mg+of+ protein+ from+ each+ SILAC+ condition+ was+ mixed+ 1:1:1.+ Proteins+ were+ digested+ initially+ with+endoproteinase+ Lys5C+ for+ 3+ hours+ (Wako),+ diluted+ threefold+ with+ 25+ mM+ tris+ buffer,+ and+ then+digested+with+trypsin+(modified+sequencing+grade,+Sigma)+overnight.+Enzyme+activity+was+quenched+by+ acidification+ of+ the+ samples+with+ trifluoroacetic+ acid+ (TFA).+ The+ peptide+mixture+was+ desalted+and+ concentrated+on+ a+C18+Sep5Pak+ cartridge+ (Waters)+ and+eluted+with+50%+acetonitrile.+ Peptide+fractionation+ was+ performed+ with+ 6+ mg+ of+ peptides+ by+ high5pH+ high5pressure+ liquid+chromatography+ (HPLC)+ essentially+ as+ described+ in+ Batth+ et+ al+ 2014+ (31).+ A+ total+ number+ of+concatenated+ fractions+was+ set+ to+10.+ From+each+ fraction+phosphopeptides+were+ enriched+by+ two+sequential+ rounds+ of+ titansphere+ chromatography.+ Briefly,+ titanium+ dioxide+ (TiO2)+ beads+ (5+ μm,+Titansphere,+GL+Sciences)+were+ incubated+with+a+solution+of+2,55dihydroxybenzoic+acid+(DHB)+(20+mg/ml)+(Sigma5Aldrich)+in+80%+ACN,+1%+TFA+for+30+min+at+room+temperature.+2+mg+of+TiO25DHB+beads+was+added+ to+ each+ fraction+and+ incubated+under+ rotation+ for+30+min+at+ room+ temperature.+The+ beads+were+washed+with+ 30%+ acetonitrile,+ 1%+TFA+ and+ transferred+ to+ a+ C8+ stage+ tip.+ Beads+were+ washed+with+ 50%+ acetonitrile,+ 1%+ TFA+ followed+ by+ 80%+ acetonitrile,+ 1%+ TFA.+ The+ bound+phosphopeptides+were+eluted+directly+into+a+965well+plate+by+5%+NH4OH+followed+by+10%+NH4OH,+25%+ACN.+The+eluate+was+ immediately+concentrated+ in+a+SpeedVac+at+45°C+and+acidified+with+5%+ACN,+1%+TFA.+Each+sample+was+then+desalted+and+concentrated+on+a+C18+stage+tip.+
Liquid5chromatography–tandem5mass5spectrometry5in5phosphoproteome5analysis5Peptides+from+all+samples+were+eluted+from+C18+stage+tips+using+40%+ACN,+0.5%+acetic+acid+before+online+ nanoflow+ LC5MS/MS+ analysis.+ Peptide+ mixtures+ were+ analyzed+ using+ a+ nanoscale+ UHPLC+system+(EASY5nLC1000+system+from+Thermo+Fisher+Scientific)+connected+to+a+Q+Exactive+HF+mass+spectrometer+ (Thermo+ Fisher+ Scientific)+ through+ a+ nanoelectrospray+ ion+ source.+ Peptides+ were+separated+ in+ a+ 155cm+ analytical+ column+ (755μm+ inner+ diameter)+ in5house+ packed+ with+ 1.95μm+reversed5phase+C18+beads+ (ReproSil5Pur+AQ,+Dr.+Maisch)+with+a+1065min+gradient+ from+8+ to+64%+acetonitrile+ in+ 0.5%+ formic+ acid+ at+ a+ flow+ rate+ of+ 250+ nl/min.+ Standard+ mass+ spectrometric+parameters+were+as+follows:+spray+voltage,+2+kV;+no+sheath+and+auxiliary+gas+flow,+heated+capillary+temperature,+275°C;+S5lens+radio+ frequency+ level+of+50%.+Full5scan+MS+spectra+ [mass/charge+ratio+(m/z),+375+ to+1500;+resolution,+120,000+at+m/z+200]+were+detected+ in+ the+Orbitrap+analyzer+after+accumulation+of+ions+at+3e6+target+value+based+on+predictive+AGC+from+the+previous+scan.+For+every+full+scan,+the+7+most+intense+ions+were+isolated+and+fragmented+(collision+energy:+28%)+by+higher5energy+ collisional+ dissociation+ (HCD)+ with+ a+ fixed+ injection/fill+ time+ of+ 110+ ms+ and+ 60,000+resolution.+Finally,+the+dynamic+exclusion+was+set+to+40+s.+
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Mass5spectrometry5data5analysis5(phosphoproteomics)5MS+raw+files+were+analyzed+using+MaxQuant+software+version+1.5.3.6+supported+by+the+Andromeda+search+ engine.+ Data+ were+ searched+ against+ a+ concatenated+ target/decoy+ (forward+ and+ reversed)+version+of+the+complete+human+UniProt+database+including+commonly+observed+contaminants+such+as+ porcine+ trypsin+ and+ bovine+ serum+ proteins.+ The+mass+ tolerance+was+ set+ to+ 6+ ppm+ for+ peptide+masses+and+20+ppm+for+HCD+fragment+ion+masses.+Cysteine+carbamidomethylation+was+searched+as+a+ fixed+ modification.+ Protein+ N5acetylation,+ N5pyroglutamine,+ deamidation+ of+ asparagine+ and+glutamine,+ oxidized+ methionine,+ and+ phosphorylation+ of+ serine,+ threonine,+ and+ tyrosine+ were+searched+as+variable+modifications.+Phosphorylation+site+localization+probabilities+were+determined+by+ MaxQuant+ using+ the+ PTM+ (post5translational+ modification)+ scoring+ algorithm+ (32,33).+ A+ false+discovery+ rate+ (FDR)+ was+ set+ to+ <+ 1%+ for+ peptide+ and+ phosphorylation+ site+ identifications.+ Only+peptides+ with+ an+ Andromeda+ score+ >+ 40+ (unmodified+ and+ modified)+ were+ included+ in+ the+ total+peptide+ list.+Minimal+peptide+ length+was+seven+amino+acids.+Only+peptides+with+a+phosphorylation+site+ localization+ probability+ of+ at+ least+ 0.75+ (32)+were+ included+ in+ the+ bioinformatic+ analyses.+ To+identify+ phosphorylation+ sites+ with+ significantly+ regulated+ ratios,+ we+ compared+ the+ ratio+distributions+of+all+quantified+phosphopeptides+with+all+nonphosphorylated+peptides+that+we+expect+not+ to+ change+ and+ therefore+ specify+ our+ technical+ variance.+ To+ determine+ the+ level+ of+ regulation,+each+treatment+condition+was+considered+an+independent+experiment+and+cutoffs+for+up5+and+down5regulation+were+ set+ to+ allow+ for+ an+ estimated+ 5%+ false5positive+ rate+ based+ on+ the+ distribution+ of+ratios+ of+ identified+ and+ quantified+ non5phosphorylated+ peptides.+ Thus,+ cutoffs+ were+ individually+determined+for+treatment+condition.+
Results&
A5parallel5combinatorial5drug5screen5reveals5distinct5Ewing5sarcoma5specific5drug$drug5interactions55We+selected+an+ initial+ library+of+ targeted+agents+ that+were+either+ clinically+ approved+or+ in+ clinical+trials.+The+library+was+comprised+of+33+targeted+compounds+representing+the+potential+new+lines+of+therapy+ in+ pediatric+ tumors+ (Supplementary+ Fig.+ S1,+ Supplementary+ Table+ S1).+ Our+ goal+ was+ to+identify+Ewing+sarcoma+specific+drug5drug+interactions+and+pinpoint+signaling+routs+that+ought+to+be+perturbed+ simultaneously+ in+ order+ to+ achieve+ strong+ synergistic+ effect+ in+ cancer+ cells+ killing.+ The+overview+ of+ the+ combinatorial+ screening+ design+ is+ shown+ in+ Fig+ 1A.+ First+ we+ determined+ drug+
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potencies+in+A673+Ewing+sarcoma+cell+line+and+the+two+cell+lines+representative+of+different+pediatric+tumor+ entities+ –+ neuroblastoma+ SH5SY5Y+ cell+ line+ and+ medulloblastoma+ UW228+ cell+ line.+ Since+synergistic+ drug+ effect+ can+ vary+ with+ the+ concentrations,+ we+ used+ a+ factorial+ dilution+ matrix+approach+ which+ enabled+ us+ to+ capture+ drug+ associations+ in+ detail+ (34)+ and+ to+ select+ for+combinations+ spread+ across+ larger+ concentration+ range.+ Due+ to+ the+ rapid+ augmentation+ of+ the+number+ of+ data+ points+ with+ every+ compound+ in+ a+ concentration+ matrix5based+ screening+ design+where+each+drug+is+combined+with+another,+we+selected+a+small+combinatorial+sub5library+of+drugs+that+ potently+ inhibited+ cancer+ cell+ growth+ in+ all+ three+ cell+ lines+ (a+ total+ of+ 18+ compounds;+Supplementary+ Fig.+ S1,+ Supplementary+ Table+ S1).+ Combinatorial+ effect+ was+ measured+ using+ the+combination+index+(CI)+method+(35)+which+is+a+quantification+of+the+Loewe+additivity+method+(36).+CI+was+calculated+for+each+of+ the+twenty5five+concentration+points+ in+which+drugs+were+combined.+We+then+assessed+the+distribution+of+levels+where+either+synergy+(CI+<+1)+or+antagonism+(CI+>+1)+was+detected,+broken+by+the+diseases+(Fig.+1B+5+1C,+Supplementary+Table+S2).+Rather+unexpectedly,+we+observed+ a+ notable+ variability+ between+ the+ tumor+ entities,+ with+ the+ highest+ overall+ rate+ of+synergistic+combinations+in+Ewing+sarcoma.++
Identification5of5a5Ewing5sarcoma5specific5synergy5between5PKC4125and5IGF1R/INSR5inhibitors55We+ sought+ for+ combinations+ that+ were+ specific+ and+ potent+ in+ Ewing+ sarcoma.+ To+ capture+ robust+synergies,+we+compared+the+sums+of+concentration+levels+with+a+very+strong+synergy+(CI+<+0.1)+for+each+ drug+ pair,+ seeking+ for+ an+ unequal+ distribution+ across+ the+ three+ cancer+ entities+ (Fig+ 2A,+Supplementary+Table+S2).+Several+drug5drug+ interactions+proved+to+be+specific+ for+Ewing+sarcoma+(Fig.+ 2A,+ bars+ predominantly+ green,+ marked+ with+ asterisks).+ We+ hypothesized+ this+ to+ be+ a+consequence+of+particular+ signaling+alterations+ caused+by+EWS5FLI1,+ thus+we+used+ it+ as+ a+ starting+point+for+a+precision+approach+to+target+ES+specific+vulnerabilities.+We+investigated+the+known+target+spectra+of+ the+ top+six+highly+synergistic+drug+pairs+and+the+database+search+results+suggested+that+the+ crucial+ processes+ responsible+ for+ the+ strong+ inhibitory+ effect+ on+ cancer+ cell+ may+ be+ the+obstruction+ of+ insulin+ and+MAPK+ signaling,+ according+ to+ the+ KEGG+ database+ (Fig.+ 2B).+ PKC412,+ a+staurosporine+ derivative+ annotated+ as+ a+ PKC/KIT+ inhibitor,+ showed+ considerable+ synergistic+potential+ in+ Ewing+ sarcoma,+ as+ well+ as+ the+ both+ IGF1R+ inhibitors+ (BMS5754807+ and+ OSI5906)+represented+ in+ the+ library+ (Fig.+ 3A).+ A+ strong+ synergy+ between+ PKC412+ and+ both+ IGF1R/INSR+inhibitors+ (CI+ <+ 0.1)+ observed+ uniquely+ in+ the+ A673+ cell+ line+ in+ up+ to+ 16+ concentration+ points+(concentration+ levels),+ was+ recapitulated+ in+ additional+ drug5drug+ matrices+ (Supplementary+ Fig.+S2A).+Moreover,+the+synergy+was+confirmed+in+a+long5term+assay+where+the+combination+efficiently+inhibited+the+colony+formation+of+A673+cells+to+a+considerably+larger+extent+than+either+of+the+drugs+
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alone+ (Fig.+ 3B).+ Annexin+ V+ immunostaining+ and+ subsequent+ flow+ cytometry+ analysis+ affirmed+ the+increased+ frequency+ of+ dead+ and+ apoptotic+ cells+ in+ the+ combination+ treated+ sample+ (Fig.+ 3C)+compared+to+the+single+drug+effects,+already+after+the+24+hours+treatment.+Next,+we+checked+whether+this+potentiation+is+a+consequence+of+alteration+of+either+drug+influx+or+drug+efflux.+Changes+ in+the+drug+transport,+however,+did+not+account+for+the+mechanism+of+synergy+between+PKC412+and+BMS5754807,+since+neither+of+the+drugs+was+interfering+with+the+intracellular+concentration+of+the+other+drug+partner+ as+ shown+by+multiple+ reaction5monitoring+ assay+ (Supplementary+ Fig.+ S2B+ and+ S2C).+Finally,+we+ tested+ the+ combination+ in+ a+ panel+ of+ Ewing+ sarcoma+ cell+ lines+ that+ differed+ regarding+sensitivity+to+single+agents+and+expressed+different+forms+of+EWS5FLI1+fusion+proteins+(variations+in+the+location+of+the+EWSR1+and+FLI$1+genomic+breakpoints),+and+all+of+them+displayed+a+comparable+synergistic+effect+(Supplementary+Table+S3).+We+hypothesized+that+although+high+dose+PKC412+may+exert+ its+ effect+ on+ the+ transcriptional+ level,+ the+ crucial+ contribution+ to+ its+ synergy+ with+ IGF1R+inhibitors+may+originate+from+the+interference+with+signaling+processes.+We+treated+A673+cells+with+high5dose+PKC412+ (5+ µM),+ combination+ of+ inhibitors+ and+ single+ drugs+ at+ concentrations+ as+ in+ the+combination,+ and+measured+mRNA+ levels+ of+ selected+ EWS5FLI1+ regulated+ genes+ such+ as+NKX.2$2,+
NR0B1+and+PHLDA1+(21,37,38).+We+compared+it+to+the+EWS5FLI1+knockdown+(kd)+sample,+since+the+A673+ cell+ line+ enables+ a+ conditional+ knockdown+of+EWS5FLI1+ in+ a+doxycycline+dependent+manner+(39).+PKC412+was+shown+to+be+a+modulator+of+EWS5FLI1+target+gene+expression+(21);+however+we+observed+ only+ a+ modest+ EWS5FLI1+ counterbalancing+ effect,+ and+ only+ upon+ high5dose+ PKC412+(Supplementary+Fig.+ S3A).+We+observed+a+ similar+ synergistic+potential+between+PKC412+and+both+IGF1R/INSR+ inhibitors,+ indicating+that+ the+ inhibition+of+ the+ IGF1R+axis+ is+ important+and+necessary+for+the+synergy+to+occur.+Upon+stimulation+with+the+IGF1R+ligand+IGF1,+phosphorylation+of+the+IGF1R+and+ INSR+and+ the+downstream+AKT+signaling+was+ impaired+by+BMS5754807+and+ the+ combination+with+PKC412;+ the+ same+pattern+was+ observed+upon+ serum+ stimulation+ (Supplementary+ Fig.+ S3B).+Further,+PKC412+is+a+multi5targeted,+promiscuous+kinase+inhibitor,+recognized+mostly+for+treatment+of+FLT3+mutated+leukemia.+FLT3+is+poorly+expressed+in+Ewing+sarcoma+and+the+target+spectrum+of+PKC412+in+this+context+was+uncharted.++Conceptually+ straightforward+ approach+ to+ decipher+ the+ target+ profile+ of+ a+ drug+ is+ chemical+proteomics,+or+drug+pulldown+(40).+To+elucidate+the+spectrum+of+proteins+interacting+with+PKC412+in+ Ewing+ sarcoma+ cells+ we+ therefore+ applied+ the+ chemical+ proteomic+ approach+ (Fig.+ 3D).+ A+coupleable+analog+of+PKC412+(41)+was+immobilized+on+sepharose+beads+and+affinity+purification+of+interacting+proteins+from+lysates+of+A673+cells+was+performed+as+described+previously+(26,41).+To+distinguish+relevant+targets+in+the+Ewing+sarcoma+background,+a+reciprocal+analysis+with+A673+cells+upon+EWS5FLI1+knockdown+was+performed.+We+assessed+the+temporal+resolution+of+the+knockdown+
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and+ selected+ the+72h+ time+point+ as+ the+best+ condition+with+a+ satisfying+knockdown+efficiency+and+minimal+ cellular+ senescence+ caused+by+EWS5FLI1+modulation+ (Fig.+ 4D).+Although+ remnants+of+ the+fusion+protein+could+still+be+detected+at+this+time+point,+the+overall+presence+and+the+impact+of+EWS5FLI1+were+drastically+impaired,+thus+allowing+us+to+distinguish+PKC412+targets+greatly+controlled+by+EWS5FLI1.+Firstly,+we+checked+whether+doxycycline+could+impede+the+results+and+we+confirmed+that+doxycycline+ does+ not+ chemically+ interfere+with+ the+ other+ two+ compounds+ (data+ not+ shown).+ Low+concentrations+ of+ tetracyclines+ inhibit+ mitochondrial+ function+ which+ could+ potentially+ confound+experimental+ outcomes.+ When+ we+ checked+ in+ detail,+ however,+ none+ of+ the+ PKC412+ targets+ we+detected+ by+ chemoproteomics+ was+ found+ in+ the+ mitochondria5related+ gene+ expression+ datasets+shown+to+be+altered+by+doxycycline+(42).+Prior+to+LC5MS/MS+analysis,+drug+pull5down+samples+from+both+ A673+ wt+ and+ EWS5FLI1+ knockdown+ conditions+ were+ verified+ by+ immunoblotting+ for+ the+presence+ of+ Aurora+ kinase+ A+ (AURKA),+ a+ known+ target+ of+ PKC412+ and+ one+ of+ the+ kinases+upregulated+by+the+EWS5FLI1+oncoprotein+(43).+Although+present+in+the+lysates+at+a+moderate+level,+AURKA+was+not+detected+in+the+pulldown+experiment+from+EWS5FLI1+silenced+cells+(Supplementary+Fig.+S3C).+Hence,+we+were+able+to+confirm+a+differential+target+profile.++We+computed+the+probability+of+true+interaction+using+the+SAINT+algorithm+(29)+and+opposed+it+to+the+magnitude+of+spectral+count+reduction+upon+competition+with+ the+ free+compound+and+we+also+considered+ the+ frequency+ of+ appearance+ in+ negative+ control+ experiments+ found+ in+ the+ CRAPome+database+(30).+Altogether,+this+allowed+us+to+capture+the+core+target+spectrum+of+PKC412+in+Ewing+sarcoma+cell+line+(Fig.+3E).+Interestingly,+when+we+compared+our+results+with+the+high+confidence+set+of+the+drug5protein+interactions+reported+in+the+computed+STITCH+database+(44)+for+PKC412+we+did+not+ find+ a+ large+ overlap.+ This+ observation+ may+ not+ be+ surprising+ given+ the+ expected+ distinct+mechanism+ of+ a+ drug+ in+ a+ particular+ EWS5FLI1+ driven+ signaling+ context+ and+ the+ unbiased+experimental+ nature+of+ our+ approach.+ In+ agreement+with+ the+ reported+ relative+promiscuity+ of+ the+drug,+the+target+spectrum+of+PKC412+distributed+across+nearly+the+entire+kinome+evolutionary+tree+(Supplementary+ Fig.+ S3D).+ Almost+ the+whole+ class+ of+ CAMKII+ kinases+was+ captured+ in+ a+ complex+with+ PKC412,+ as+ well+ as+ other+ cognate+ calcium+ signaling+ kinases,+ such+ as+ PRKCA,+ PRKCB+ and+PDGFRB,+arguing+for+a+thorough+blockade+of+the+pathway+(Fig.+3E).+Interestingly,+PDGFR+is+involved+in+mediating+resistance+to+BMS5754807+in+a+human+rhabdomyosarcoma+model+(45).+We+detected+a+number+of+high5confidence+ interactors+ that+are+ related+ to+ insulin+ signaling+according+ to+ the+KEGG+database+ (PDPK1,+ PRKAA2,+ PRKAB1,+ PRKAB2)+ (46).+ Moreover,+ PDPK1+ can+ phosphorylate+ and+activate+AKT,+ allowing+a+ cellular+ response+ to+ stimuli+ such+as+ growth+ factors+ and+ insulin+ signaling.+Overlap+between+the+PI3K/AKT/mTOR+and+insulin+pathways+pointed+to+another+interacting+protein+of+PKC412,+ULK3+(Unc551+Like+Kinase+3),+a+known+regulator+of+autophagy,+seemingly+dependent+on+
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EWS5FLI1+presence+(Supplementary+Fig.+S3E).+A+number+of+the+remaining+PKC412+targets,+such+as+FER,+MAP/microtubule+affinity5regulating+kinase+MARK2,+discoidin+domain+receptor+kinase+DDR2,+TBK1+and+ the+ interactor+TANK,+are+also+well5associated+with+ the+PI3K/AKT/mTOR+pathway+ (47).+Altogether,+ we+ concluded+ that+ PKC412+ may+ exert+ its+ cytotoxic+ effect+ by+ inhibiting+ crucial+ Ewing+sarcoma+ signaling+ routes+ –+ calcium,+ insulin+ and+mTOR+ pathways.+ Moreover,+ we+ showed+ that+ the+combination+ of+ PKC412+ with+ an+ IGF1R/INSR+ inhibitor+ exhibited+ strong+ short5+ and+ long5term+synergy+ in+ a+ broad+ range+ of+ concentrations+ and+ in+ a+ variety+ of+ Ewing+ sarcoma+ cell+ line+ model+systems.+
Quantitative5 phosphoproteomics5 identifies5 functionally5 relevant5 signaling5 networks5 altered5 by5 the5
drug5combination5in5the5context5of5Ewing5sarcoma5Following+up+on+ the+PKC412+ target+profiling,+we+set+out+ to+ investigate+ the+consequences+of+ single+and+combinatorial+drug+treatment+on+the+crucial+signaling+pathways.+We+compared+three+different+conditions+(PKC412+treated,+BMS5754807+treated+and+combination+treated+A673+cells)+to+the+DMSO+treated+A673+cells+using+a+quantitative+proteomics+approach+(48),+where+stable+isotope+labeling+by+amino+ acids+ in+ cell+ culture+ (SILAC)+ was+ combined+ with+ high5resolution+ liquid+ chromatography–tandem+mass+spectrometry+(LC5MS/MS)+(experimental+overview+given+in+Supplementary+Fig.+S4A).+The+ numbers+ of+ identified+ phosphosites+ were+ in+ agreement+ with+ previous+ studies+ (32,49)+ and+different+drug+treatments+displayed+a+good+reproducibility+with+a+Pearson+correlation+R+in+the+range+of+0.6250.82+(Supplementary+Fig.+S4B+and+S4C).+As+expected,+the+majority+of+phosphorylation+sites+regulated+ by+ single+ drugs+ were+ overlapping+ with+ the+ combination+ treatment.+ Out+ of+ 667+ sites+downregulated+by+the+combination,+more+than+half+(386)+were+uniquely+altered+by+the+combination+(Fig.+4A).+The+same+was+evident+with+the+compound5induced+upregulation+of+phosphorylation+sites+(Fig.+4A),+arguing+for+the+exclusive+mechanism+of+the+combined+effect.+Phosphorylation+site+changes+were+ visualized+ by+ hierarchical+ clustering,+where+we+ implemented+ a+ cluster5dependent+ sequence+motif+ enrichment+ analysis+ of+ the+ phosphorylation+ sites+ and+ observed+ a+ strong+ preference+ for+PKC/AKT+and+MAPK+motifs+(Fig.+4B).+Interestingly,+an+ATM/ATR+motif+was+upregulated+by+PKC412+and+ the+ combinatorial+ treatment,+ possibly+ due+ to+ the+ activation+ of+ stress+ related+ DNA+ damage+inducing+pathways.+ The+ overall+ effect+ of+ the+ combinatorial+ treatment+ that+we+ observed+was+ truly+synergistic+in+nature,+since+it+encompassed+single+effects+of+both+of+the+drugs+and+supplemented+an+additional+combinatorial+response+that+was+distinct+from+the+overlap+of+the+single+drugs+effect+and+resulted+in+an+additional+alternation+of+core+signaling+processes.+KEGG+pathway+enrichment+analysis+suggested+ the+ MAPK+ pathway,+ mTOR+ signaling,+ and+ the+ insulin+ pathway+ as+ some+ of+ the+ of+ sites+downregulated+ specifically+ by+ combination.+ (Supplementary+ Fig.+ S4D,+ Supplementary+ Fig.+ S5).+ In+
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concordance+ with+ the+ PKC412+ chemical+ proteomic+ data,+ the+ combination+ treatment+ indicated+ an+overrepresentation+ of+ PKA+ and+ CaMKII+motifs+ for+ downregulated+ sites+ (Supplementary+ Fig.+ S4E).+For+ a+ number+ of+ relevant+ phosphoproteins+we+ observed+ a+ considerably+ stronger+ downregulation+when+ drugs+ were+ applied+ together+ compared+ to+ PKC412+ alone+ at+ the+ same+ concentration.+ For+instance,+ this+ held+ true+ for+ a+ number+ of+ Ca2+/calmodulin+ dependent+ kinases+ (CAMK2D,+ DAPK2,+CAMK1,+PRKCB).+Some+of+ those+have+been+shown+to+be+PKC412+targets+but+ the+overall+effect+was+decidedly+potentiated+by+ the+ second+drug.+Since+ the+cluster5dependent+ sequence+motif+ analysis+of+the+phosphorylation+sites+pointed+to+a+preference+for+AKT,+MAPK+and+ERK1/2+(extracellular5signal5regulated+kinases),+we+checked+it+in+more+detail.++Similarly+ to+ rapamycin+ (mTORC1+ inhibitor)+ and+ torin+ (dual+mTORC1+ and+mTORC2+ inhibitor)+ the+PKC412/BMS5754807+combination+inhibited+activation+of+the+mTOR+pathway,+demonstrated+by+its+hallmark+ phosphorylation+ of+ a+ downstream+ TORC1+ effector+ p70S6+ kinase+ (S6K)+ at+ the+ threonine+residue+ 389+ (T389)+ (Fig.+ 4C).+ The+ effect+ of+ the+ combination+ was+ considerably+ stronger+ than+ the+effect+of+the+either+of+the+drugs+alone.+As+an+mTORC1+inhibitor,+rapamycin+failed+to+down5regulate+TORC2+dependent+AKT+phosphorylation+on+serine+473+(S473),+while+this+phosphorylation+site+was+strongly+ inhibited+ by+ torin+ and,+ notably,+ by+ the+ synergistic+ combination.+ Moreover,+ both+ mTOR+inhibitors+ induced+ the+ suppression+ of+ a+ negative+ feedback+ loop,+which+ leads+ to+ the+AKT+ pathway+stimulation+and+subsequent+ cell+ survival+ (50),+ identified+ through+phosphorylation+on+ the+ catalytic+site+for+AKT+activation,+threonine+308+(T308).+Importantly,+this+compensatory+re5activation+was+not+induced+ by+ the+ PKC412/IGF1R+ inhibitor+ combination;+ on+ the+ contrary,+ combination+ treatment+caused+potent+ inhibition+of+T308+AKT+phosphorylation.+Rewiring+of+signaling+networks+was+hence+circumvented,+ a+ notion+ strengthened+by+ the+ observed+ inhibition+ of+ the+ ERK1/p44+ and+ERK2/p42+activation+by+ the+combination,+although+seen+ intermittently+ (Fig.+4C+and+Supplementary+Fig.+S4F).+This+argued+for+an+exhaustive+impairment+of+the+cross5talk+between+various+pro5survival+pathways.+Identical+series+of+signaling+inhibition+was+observed+when+OSI5906,+another+IGF1R/INSR+inhibitor,+was+used+instead+of+BMS5754807+in+combination+with+PKC412+(Supplementary+Fig.+S4F).+Finally,+to+check+ for+EWS5FLI1+dependence,+we+performed+the+knockdown+of+EWS5FLI1+ in+ the+A673+cell+ line+(Fig.+4D)+and+assessed+the+profile+of+signaling+changes+after+72h+upon+the+knockdown+induction+(Fig.+4E).+ While+ the+ mTOR+ inhibitors+ exhibited+ an+ identical+ pattern+ as+ in+ the+ wild+ type+ cells,+ the+PKC412/BMS5754807+ combination+ treatment+ was+ suddenly+ ineffective,+ demonstrating+ the+dependency+of+the+effect+to+the+EWS5FLI1+altered+signaling.+Similar+pattern+of+signaling+events+as+in+A673+cells+we+observed+in+additional+Ewing+sarcoma+cell+lines,+TC71+and+TC252+(Fig.+4F),+while+the+combination+ was+ ineffective+ in+ the+ two+ non5Ewing+ cell+ lines,+ medulloblastoma+ UW228+ and+
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neuroblastoma+IMR5575+cells,+although+mTOR+inhibitors+were+still+effective+(Fig.+4G).+We+concluded+that+ the+ overall+ effect+ of+ the+ combinatorial+ treatment+ is+ the+ consequence+ of+ an+ exclusive+combinatorial+response+that+resulted+in+thorough+alteration+of+core+signaling+processes+determined+by+EWS5FLI1+and+important+for+the+Ewing+sarcoma+tumor+survival+and+progression.+
Discussion&Resistance+to+targeted+agents+occurs+frequently+and+poses+a+major+limitation+in+clinical+practice.+It+can+be+caused+by+various+molecular+mechanisms+that+cancer+cells+adopt+when+challenged+with+small+molecule+drugs+ for+prolonged+periods+(51,52).+Compensatory+pathways+can+remodel+ the+signaling+landscape+ and+ cause+ drug+ ineffectiveness+ (53).+ However,+ synergistic+ activity+ of+ two+ drugs+ with+distinct+ primary+ mechanism+ of+ action,+ can+ improve+ treatment+ efficacy,+ especially+ in+ complex+diseases+ where+ the+ control+ is+ more+ likely+ to+ be+ accomplished+ by+ using+ multiple+ interventions+(54,55).+ By+ charting+ disease+ specific+ functional+ synergies+ onto+ pathways,+ we+ aimed+ to+ decipher+synergistic+ signaling+ cross5talks+ in+ a+ particular+ Ewing+ sarcoma+ context.+ We+ observed+ a+ strong+synergistic+ potential+ of+ PKC412+ specifically+ in+ the+ Ewing+ sarcoma+ combinatorial+ screen,+ notably+with+IGF1R/INSR+inhibitors.+Target+spectrum+analysis+of+PKC412+in+Ewing+sarcoma+revealed+that+in+the+absence+of+its+main+cognate+targets+(56)+and+in+a+particular+signaling+background+directed+by+the+fusion+ oncoprotein+ EWS5FLI1,+ PKC412+ exhibited+ its+ cytotoxic+ effect+ primarily+ by+ suppression+ of+signaling+routes+that+appeared+to+be+the+most+prominent+in+Ewing+sarcoma:+the+PI3K/AKT/mTOR,+insulin+ and+ calcium/calmodulin+ signaling+ axes+ (17).+ IGF1R+ inhibitors,+ both+ antibody5based+ and+small+ molecules,+ are+ considered+ an+ exciting+ option+ in+ precision+ medicine5based+ Ewing+ sarcoma+treatment,+since+IGF1+signaling+is+known+to+be+heavily+altered+in+Ewing+sarcoma+due+to+a+number+of+related+ EWS5FLI1+ target+ genes+ (15).+ Yet,+ it+ proved+ to+ be+ difficult+ to+ identify+ patients+ that+ would+benefit+ from+ the+ therapy+ and+ even+ in+ responsive+ patients+ resistance+ occurred+ frequently+ (16,57).+Combination+of+PKC412+with+ the+ two+ IGF1R/INSR+small+molecule+ inhibitors+was+consistently+and+strongly+ synergistic+ in+ a+ panel+ of+ assorted+ Ewing+ sarcoma+ cell+ lines,+ while+ mild+ antagonism+ or+additivity+was+observed+in+parallel+screens+in+neuroblastoma+and+medulloblastoma.+Advantageously+for+a+possible+therapeutic+application,+the+effect+was+spread+across+a+broad+range+of+concentrations,+arguing+ for+ a+ potentially+ wide+ application.+ Mechanistically,+ the+ combination+ triggered+ a+ different+array+ of+ responses+ in+ cancer+ cells+ compared+ to+ a+ single+ drug+ treatment.+ A+ significant+ portion+ of+
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regulated+ phosphorylated+ sites+ was+ found+ to+ be+ unique+ for+ the+ combination+ treatment,+ strongly+arguing+ that+ the+ combined+ effect+ was+ more+ than+ a+ simple+ sum+ of+ the+ individual+ events.+ A+coordinated+ inhibition+ of+ AKT/PI3K/mTOR+ and+ MAPK+ signaling+ pathways+ was+ considerably+stronger+ by+ the+ combination+ than+by+ either+ of+ the+drugs+ alone.+ Importantly,+ this+ effect+was+EWS5FLI1+ dependent,+ unlike+ in+ case+ of+ mTOR+ inhibitors.+ Moreover,+ compensatory+ suppression+ of+ the+negative+ feedback+ loops+ was+ surpassed+ by+ the+ simultaneous+ application+ PKC412+ and+ the+IGF1R/INSR+inhibitor,+potentially+leading+to+overcoming+the+resistance.+The+reduced+dosing+enabled+by+ the+ synergistic+ effect+ would+ lessen+ the+ associated+ adverse+ side+ effects,+ which+ is+ particularly+important+ in+pediatric+ tumors+where+patients+ experience+ long5term+ treatment+ consequences.+ The+Ewing+sarcoma5specific+combinations+of+targeted+agents+that+we+identified+have+the+potential+to+be+readily+translated+into+clinical+treatment.+This+is+particularly+important+as+improvements+in+survival+for+Ewing+sarcoma+patients+have+been+modest.+We+paved+the+way+for+in$silico+synergy+modeling+by+mapping+chemical+perturbations+in+three+pediatric+tumors+in+a+comparable+manner,+which+can+also+allow+for+a+better+understanding+of+the+complex+disease+system+itself.+
& +
20"
"
References&
1.  Gorlick R, Janeway K, Lessnick S, Randall RL, Marina N, Committee  on behalf of the 
COGBT. Children’s Oncology Group’s 2013 blueprint for research: Bone tumors. Pediatr 
Blood Cancer. 2013;60:1009–15.  
2.  Smith MA, Seibel NL, Altekruse SF, Ries LAG, Melbert DL, O’Leary M, et al. Outcomes 
for Children and Adolescents With Cancer: Challenges for the Twenty-First Century. J 
Clin Oncol. 2010;28:2625–34.  
3.  Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, et al. The 
Genomic Landscape of Pediatric Ewing Sarcoma. Cancer Discov. 2014;4:1326–41.  
4.  Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, et al. Gene fusion with 
an ETS DNA-binding domain caused by chromosome translocation in human tumours. 
Nature. 1992;359:162–5.  
5.  May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, et al. The Ewing’s 
sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a 
more powerful transforming gene than FLI-1. Mol Cell Biol. 1993;13:7393–8.  
6.  Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, et al. Genomic 
Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of 
STAG2 and TP53 Mutations. Cancer Discov. 2014;4:1342–53.  
7.  Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, et al. The Genomic 
Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation. 
PLoS Genet. 2014;10:e1004475.  
8.  Lerman DM, Monument MJ, McIlvaine E, Liu X, Huang D, Monovich L, et al. Tumoral 
TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with 
localized Ewing sarcoma: A report from the Children’s Oncology Group. Pediatr Blood 
Cancer. 2015;62:759–65.  
9.  Herrero-Martin D, Fourtouna A, Niedan S, Riedmann LT, Schwentner R, Aryee DNT. 
Factors Affecting EWS-FLI1 Activity in Ewing’s Sarcoma. Sarcoma. 2011;2011:352580.  
10.  Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, et al. DNA-binding 
and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from 
the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol. 1994;14:3230–41.  
11.  Schwentner R, Papamarkou T, Kauer MO, Stathopoulos V, Yang F, Bilke S, et al. EWS-
FLI1 employs an E2F switch to drive target gene expression. Nucleic Acids Res. 
2015;43:2780–9.  
12.  Potratz J, Tillmanns A, Berning P, Korsching E, Schaefer C, Lechtape B, et al. Receptor 
tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential 
therapeutic target in metastatic disease. Mol Oncol. 2016;10:677–92.  
13.  Scotlandi K, Benini S, Sarti M, Serra M, Lollini P-L, Maurici D, et al. Insulin-like Growth 
Factor I Receptor-mediated Circuit in Ewing’s Sarcoma/Peripheral Neuroectodermal 
Tumor: A Possible Therapeutic Target. Cancer Res. 1996;56(20):4570–4.  
14.  Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ. The Insulin-like Growth 
Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts. J Biol Chem. 
1997;272(49):30822–7.  
15.  Cironi L, Riggi N, Provero P, Wolf N, Suvà M-L, Suvà D, et al. IGF1 Is a Common Target 
Gene of Ewing’s Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells. PLoS One. 
2008;3(7):e2634.  
16.  Naing A, LoRusso P, Fu S, Hong DS, Anderson P, Benjamin RS, et al. Insulin Growth 
21"
"
Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor 
Temsirolimus in Patients with Refractory Ewing’s Sarcoma Family Tumors. Clin Cancer 
Res. 2012;18(9):2625–31.  
17.  Toretsky JA, Thakar M, Eskenazi AE, Frantz CN. Phosphoinositide 3-Hydroxide Kinase 
Blockade Enhances Apoptosis in the Ewing’s Sarcoma Family of Tumors. Cancer Res. 
1999;59(22):5745–50.  
18.  Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and 
challenges. Nat Rev Drug Discov. 2014;13(12):928–42.  
19.  Jiang Y, Ludwig J, Janku F. Targeted therapies for advanced Ewing sarcoma family of 
tumors. Cancer Treat Rev. 2015;41(5):391–400.  
20.  Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response 
surface perspective. Pharmacol Rev. 1995;47(2):331–85.  
21.  Boro A, Prêtre K, Rechfeld F, Thalhammer V, Oesch S, Wachtel M, et al. Small-molecule 
screen identifies modulators of EWS/FLI1 target gene expression and cell survival in 
Ewing’s sarcoma. Int J Cancer. 2012;131(9):2153–64.  
22.  Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, et al. Insulin 
Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in 
Human Osteosarcoma. Cancer Res. 2009;69(6):2443–52.  
23.  Chen HX, Sharon E. IGF-1R as an anti-cancer target—trials and tribulations. Chin J 
Cancer. 2013;32(5):242–52.  
24.  Chou T-C. Theoretical Basis, Experimental Design, and Computerized Simulation of 
Synergism and Antagonism in Drug Combination Studies. Pharmacol Rev. 
2006;58(3):621–81.  
25.  Rix U, Hantschel O, Dürnberger G, Remsing Rix LL, Planyavsky M, Fernbach N V, et al. 
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib 
reveal novel kinase and nonkinase targets. Blood. 2007;110(12):4055–63.  
26.  Radic-Sarikas B, Rix U, Stukalov A, Gridling M, Müller AC, Colinge J, et al. Enhancing 
cognate target elution efficiency in gel-free chemical proteomics. EuPA Open Proteomics. 
2015;9:43–53.  
27.  Maurer M, Müller AC, Wagner C, Huber ML, Rudashevskaya EL, Wagner SN, et al. 
Combining Filter-Aided Sample Preparation and Pseudoshotgun Technology To Profile 
the Proteome of a Low Number of Early Passage Human Melanoma Cells. J Proteome 
Res. 2013;12:1040–8.  
28.  Kersey P, Hermjakob H, Apweiler R. VARSPLIC: alternatively-spliced protein sequences 
derived from SWISS-PROT and TrEMBL. Bioinformatics. 2000;16:1048–9.  
29.  Choi H, Larsen B, Lin Z-Y, Breitkreutz A, Mellacheruvu D, Fermin D, et al. SAINT: 
probabilistic scoring of affinity purification-mass spectrometry data. Nat Meth. 2011;8:70–
3.  
30.  Mellacheruvu D, Wright Z, Couzens AL, Lambert J-P, St-Denis NA, Li T, et al. The 
CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat 
Meth. 2013;10:730–6.  
31.  Batth TS, Francavilla C, Olsen J V. Off-Line High-pH Reversed-Phase Fractionation for 
In-Depth Phosphoproteomics. J Proteome Res. 2014;13:6176–86.  
32.  Olsen J V., Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, In Vivo, 
and Site-Specific Phosphorylation Dynamics in Signaling Networks. Cell. 2006;127:635–
48.  
33.  Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-
22"
"
range mass accuracies and proteome-wide protein quantification. Nat Biotech. 
2008;26:1367–72.  
34.  Lehár J, Stockwell BR, Giaever G, Nislow C. Combination chemical genetics. Nat Chem 
Biol. 2008;4:674–81.  
35.  Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined 
effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.  
36.  Loewe S, Muischnek H. Über Kombinationswirkungen. Naunyn Schmiedebergs Arch Exp 
Pathol Pharmakol. 1926;114:313–26.  
37.  Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, Golub TR, et al. Expression 
profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing’s sarcoma. 
Cancer Cell. 2006;9:405–16.  
38.  Kinsey M, Smith R, Lessnick SL. NR0B1 Is Required for the Oncogenic Phenotype 
Mediated by EWS/FLI in Ewing’s Sarcoma. Mol Cancer Res. 2006;4:851–9.  
39.  Carrillo J, García-Aragoncillo E, Azorín D, Agra N, Sastre A, González-Mediero I, et al. 
Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor Growth. 
Clin Cancer Res. 2007;13:2429–40.  
40.  Rix U, Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat 
Chem Biol. 2009;5:616–24.  
41.  Borgdorff V, Rix U, Winter GE, Gridling M, Muller AC, Breitwieser FP, et al. A chemical 
biology approach identifies AMPK as a modulator of melanoma oncogene MITF. 
Oncogene. 2014;33:2531–9.  
42.  Moullan N, Mouchiroud L, Wang X, Ryu D, Williams EG, Mottis A, et al. Tetracyclines 
disturb mitochondrial function across eukaryotic models: A call for caution in biomedical 
research. Cell Rep. 2015;10:1681–91.  
43.  Winter GE, Rix U, Lissat A, Stukalov A, Müllner MK, Bennett KL, et al. An Integrated 
Chemical Biology Approach Identifies Specific Vulnerability of Ewing’s Sarcoma to 
Combined Inhibition of Aurora Kinases A and B. Mol Cancer Ther. 2011;10:1846–56.  
44.  Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P. STITCH: interaction networks 
of chemicals and proteins. Nucleic Acids Res. 2008;36:D684–8.  
45.  Huang F, Hurlburt W, Greer A, Reeves KA, Hillerman S, Chang H, et al. Differential 
Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody 
Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma 
Model. Cancer Res. 2010;70:7221–31.  
46.  Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, et al. Comprehensive 
analysis of kinase inhibitor selectivity. Nat Biotechnol. 2011;29:1046–51.  
47.  Ou Y-H, Torres M, Ram R, Formstecher E, Roland C, Cheng T, et al. TBK1 directly 
engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell. 
2011;41:458–70.  
48.  Olsen J V, Mann M. Status of Large-scale Analysis of Post-translational Modifications by 
Mass Spectrometry. Mol Cell Proteomics. 2013;12:3444–52.  
49.  Emdal KB, Pedersen A-K, Bekker-Jensen DB, Tsafou KP, Horn H, Lindner S, et al. 
Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase 
Cbl-b in neuroblastoma cell differentiation. Sci Signal. 2015;8:ra40-ra40.  
50.  Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, et al. DEPTOR 
Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required 
for Their Survival. Cell. 2009;137:873–86.  
51.  Groenendijk FH, Bernards R. Drug resistance to targeted therapies: déjà vu all over again. 
23"
"
Mol Oncol. 2014;8:1067–83.  
52.  Wood KC. Mapping the Pathways of Resistance to Targeted Therapies. Cancer Res. 
2015;75:4247–51.  
53.  Rozengurt E, Soares HP, Sinnet-Smith J. Suppression of feedback loops mediated by 
PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended 
consequence leading to drug resistance. Mol Cancer Ther. 2014;13:2477–88.  
54.  Feala JD, Cortes J, Duxbury PM, Piermarocchi C, McCulloch AD, Paternostro G. Systems 
approaches and algorithms for discovery of combinatorial therapies. Wiley Interdiscip Rev 
Syst Biol Med. 2010;2:181–93.  
55.  Wildenhain J, Spitzer M, Dolma S, Jarvik N, White R, Roy M, et al. Prediction of 
Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Syst. 
2016;1:383–95.  
56.  Peter B, Winter GE, Blatt K, Bennett KL, Stefanzl G, Rix U, et al. Target interaction 
profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects 
on activation and growth. Leukemia. 2016;30:464–72.  
57.  Arnaldez FI, Helman LJ. New strategies in ewing sarcoma: lost in translation? Clin Cancer 
Res. 2014;20:3050–6.  
&Acknowledgements&We+ thank+ Georg+ Winter,+ Uwe+ Rix,+ Claudia+ Trefzer,+ Eleni+ Tomazou,+ Konstantinos+ Papakostas,+Johannes+Bigenzahn,+Dorte+B.+Bekker5Jensen,+Anna5Kathrine+Pedersen+ and+Dave+Aryee+ for+ skillful+advice+ and+help.+We+also+want+ to+ thank+ for+ the+generous+gifts+of+ cell+ lines+or+ reagents,+Alexandre+Arcaro,+Javier+Alonso,+and+Frank+Westermann.++
Data&and&materials&availability:++The+raw+MS+data+and+associated+ tables+have+been+deposited+ to+ the+ProteomeXchange+Consortium+via+ the+ PRIDE+ partner+ repository+ with+ the+ data+ set+ identifier+ PXD002765+(http://proteomecentral.proteomexchange.org).+
24"
"
Figure legends 
Fig. 1. Drug5drug+interactions+identified+in+combinatorial+drug+screens+in+the+three+pediatric+tumor+cell+ lines.+ (A)+ Workflow+ of+ a+ dilution5matrix+ based+ parallel+ combinatorial+ screens+ in+ the+three+pediatric+tumor+entities.+(B)+Distribution+of+synergy+across+the+three+screens;+shown+is+a+number+of+concentration+levels+where+for+each+cell+line+CI+<+1+and+CI+>+1+in+the+remaining+two+cell+ lines.+The+drug+pair+was+concealed+ in+cases+CI+=+0+or+when+CI+was+not+ calculable.+Blue,+ neuroblastoma;+ green,+ Ewing+ sarcoma;+ red,+ medulloblastoma.+ (C)+ Distribution+ of+antagonism+ across+ the+ three+ tumor+ entities;+ shown+ is+ a+ number+ of+ concentration+ levels+where+ in+each+cell+ line+CI+>1+and+CI+<+1+ in+ the+remaining+two+cell+ lines.+The+drug+pair+was+concealed+ in+cases+CI=0+or+when+CI+was+not+calculable.+Blue,+neuroblastoma;+green,+Ewing+sarcoma;+red,+medulloblastoma. 
Fig.&2.&Ewing+sarcoma5specific+synergies+converge+around+same+signaling+axes.+ (A)+Distribution+of+very+ strong+ synergy+ (CI+ <+ 0.1)+ across+ concentration+ levels+ in+ the+ three+ pediatric+ tumor+entities.+Shown+is+a+number+of+concentration+levels+where+for+each+cell+line+CI+<+0.1+and+CI+>+1+ in+ the+ remaining+ two+ cell+ lines.+ Blue,+ neuroblastoma;+ green,+ Ewing+ sarcoma;+ red,+medulloblastoma.+Six+pairs+with+the+strongest+Ewing+sarcoma5specific+synergistic+effect+are+emboldened+ in+ black+ and+marked+with+ stars.+ (B)+ Network+ representing+ targets+ of+ the+ six+most+ prominent+ Ewing+ sarcoma+ specific+ synergistic+ drug+ pairs.+ Affected+ processes+ are+outlined,+according+to+the+KEGG+database.+
Fig.&3.+Interaction+between+PKC412+and+IGF1R/INSR+inhibitors+is+synergistic+in+Ewing+sarcoma.+(A)+Chemical+ structures+of+PKC412+and+ the+ two+ IGF1R+ inhibitors+ from+ the+panel,+OSI5906+and+BMS5754807.+ (B)+ Colony+ formation+ assay.+ PKC412+ (red+ border)+ was+ used+ at+ 0.25+ IC50+concentration+ (75+ nM),+ BMS5754807+ (green+ border)+ at+ 0.25+ IC50+ (18+ nM).+ DMSO+ (grey+border)+ treated+cells+were+used+as+a+ control.+Data+ shown+as+mean+±+ s.e.m.+and+ images+are+representative+ of+ triplicate+ experiments+ (P+ <+ 0.05,+ t5test).+ (C)+ AnnexinV/DAPI+ staining+ of+A673+cells+after+24+h+of+compound+treatment+with+PKC412+at+150+nM+(0.5+IC50)+and+BMS5754807+ at+ 35+ nM+ (0.5+ IC50).+ The+ percentage+ of+ apoptotic,+ dead,+ and+ alive+ cells+ was+determined+and+data+ are+ shown+as+means+±+ s.d.+ from+ three+ independent+ experiments.+ (D)+Schematic+of+the+chemical+proteomic+workflow.+(E)+Results+ from+mass5spectrometry5based+proteomic+ affinity+ purification+ experiment+ using+ competition+ analysis+ and+ SAINT.+ Data+shown+are+based+on+two+independent+experiments+for+each+condition+(A673+cell+lysate+and+A673+ lysate+ pretreated+ with+ the+ free+ drug,+ i.e.+ competition+ pull5down);+ each+ biological+replicate+was+analyzed+in+two+technical+replicates.+
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Fig.&4.+Quantitative+phosphoproteomics+ identifies+PKC/AKT/mTOR+and+MAPK+ signaling+networks+as+ functionally+ relevant+ for+ the+ synergistic+ effect+ of+ the+ drug+ combination.+ (A)+ Overlap+ of+altered+ phosphorylation+ sites+ upon+ single+ drugs+ and+ combinatorial+ treatment.+ (B)+Hierarchical+ clustering+ of+ phosphorylation+ site+ changes+ including+ cluster5dependent+sequence+motif+enrichment+analysis+of+the+phosphorylation+sites.+(C)+Immunoblots+showing+changes+ in+ phosphorylation+ of+ representative+ PKC/AKT/mTOR+ and+ MAPK+ kinases+ after+combinatorial+drug+treatment.+Cells+were+starved+overnight,+treated+as+indicated+for+2h+and+stimulated+ with+ serum+ for+ 20+ minutes.+ Treatment+ doses:+ PKC412:+ 75+ nM+ (!!+ IC50);+BMS754807:+ 18+ nM+ (!!+ IC50);+ combination:+ concurrently+ 75+ nM+ PKC412+ and+ 18+ nM+BMS754807;+ torin:+ 250+ nM;+ rapamycin:+ 1+ µM.+ (D)+ Temporal+ resolution+ of+ the+ EWS5FLI1+knockdown.+ 72h+ time+ point+ was+ selected+ for+ the+ chemical+ proteomic+ and+ immunoblot+experiment.+ (E)+ Immunoblot+ showing+ changes+ in+ phosphorylation+ upon+ drug+ treatment+when+ EWS5FLI1+ knockdown+was+ induced.+ At+ the+ 72h+ doxycyclin+ induction+ time+ point+ the+cells+were+starved+overnight,+ treated+as+ indicated+for+2h+and+stimulated+with+serum+for+20+minutes.+ Treatment+ doses:+ PKC412:+ 75+ nM+ (!!+ IC50);+ BMS754807:+ 18nM+ (!!+ IC50);+combination:+ concurrently+ 75+ nM+ PKC412+ and+ 18+ nM+ BMS754807;+ torin:+ 250+ nM;+rapamycin:+ 1+µM.+ (F)+ Immunoblots+upon+drug+ treatment+ in+ additional+Ewing+ sarcoma+ cell+lines+ TC71+ and+ TC252.+ Cells+ were+ starved+ overnight,+ treated+ as+ indicated+ for+ 2h+ and+stimulated+with+serum+for+20+minutes.+Treatment+doses:+PKC412:+!!+IC50+(1100+nM+in+TC71,+10.5+nM+in+TC252);+BMS754807:+!!+ IC50+(320+nM+in+TC71,+8.5+nM+ in+TC252);+combination:+concurrently+!!+ IC50+PKC412+and+!!+ IC50+BMS754807;+torin:+250+nM;+rapamycin:+1+µM.+n=2.+(G)+ Immunoblots+upon+drug+ treatment+ in+additional+non5Ewing+sarcoma+cell+ lines,+UW228+(medulloblastoma)+and+IMR5575+(neuroblastoma).+Cells+were+starved+overnight,+ treated+as+indicated+ for+ 2h+ and+ stimulated+ with+ serum+ for+ 20+minutes.+ Treatment+ doses:+ PKC412:+ !!+IC50+(125+nM+in+UW228,+36+nM+in+IMR5575);+BMS754807:+!!+IC50+(250+nM+in+UW228,+96+nM+in+ IMR5575);+combination:+concurrently+ !!+ IC50+PKC412+and+ !!+ IC50+BMS754807;+ torin:+250+nM;+rapamycin:+1+µM.+++




